Sowell Financial Services LLC Bluebird Bio, Inc. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$18.04 - $22.09 $13,728 - $16,810	-761 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$16.59 - $33.89 $8,709 - $17,792	525 Added 222.46%	761 $23,000
Q4 2020 Jan 13, 2021	BUY	$27.5 - $37.92 $3,987 - $5,498	145 Added 159.34%	236 $10,000
Q3 2020 Nov 12, 2020	BUY	$34.44 - $43.75 $3,134 - $3,981	91 New	91 $5,000
Q1 2020 May 12, 2020	SELL	$26.16 - $63.5 $1,177 - $2,857	-45 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$46.96 - $61.67 $422 - $555	-9 Reduced 16.67%	45 $2,000
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $3,211 - $5,027	54 New	54 $5,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.